NervGen Pharma Corp. Common stock (NGEN)
search
Earnings reactions
How NGEN moved on each past earnings report.
Up
Down
Earnings Impact
NervGen Pharma Corp. Common stock (NGEN) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
NervGen Pharma Corp. Common stock (NGEN) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 9 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
9
Funds holding
$2005927
Total value held
Buying
8 added · 1 reduced
Ubs Group Ag
$782236
NEW BUY
Bank Of America Corp /De/
$383572
-7.20%
Royal Bank Of Canada
$363000
+2.39%
Bank Of Montreal /Can/
$284382
+24.63%
Sprott Inc.
$51500
NEW BUY
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 6-K | 20260813 | open_in_new SEC.gov |
| 6-K | 20260702 | open_in_new SEC.gov |
| SUPPL | 20260702 | open_in_new SEC.gov |
| 6-K | 20260601 | open_in_new SEC.gov |
| EFFECT | 20260526 | open_in_new SEC.gov |
| 6-K | 20260526 | open_in_new SEC.gov |
| F-10 | 20260526 | open_in_new SEC.gov |
| F-X | 20260526 | open_in_new SEC.gov |
| SUPPL | 20260526 | open_in_new SEC.gov |
| 6-K | 20260522 | open_in_new SEC.gov |